Among 12 thyrotoxic patients, a patient with arrhythmogenic right ventricular dysplasia, who had been taking amiodarone for 4 years, developed thyrotoxicosis with subacute onset, accompanied by transiently positive thyrotropin (TSH) receptor antibody (TRAb), or thyrotropin-binding inhibiting immunoglobulin (TBII).
thyrotropin-binding inhibiting immunoglobulin
amiodarone
thyrotoxicosis
amiodarone
transiently positive thyrotropin (TSH) receptor antibody
amiodarone